Advances in blood-based biomarkers are transforming Alzheimer's disease research, but standard venous draws and lab requirements limit broad accessibility—especially in remote or resource-constrained settings. A recent study from the University of Gothenburg, published in Alzheimer’s & Dementia, demonstrates the potential of Dried Plasma Spot sampling combined with ultrasensitive Simoa® detection as a reliable, stable, and scalable method for AD biomarker analysis. This approach could pave the way for decentralized, early detection and monitoring of Alzheimer’s disease. Read the full study highlight to learn more: https://lnkd.in/ewhfjbwf #AlzheimersDisease #Neurodegeneration #DriedPlasmaSpot
